Evidence map›Paper›PMID 25238489›Full record

ArticleOrganic letters2014

Rare Streptomyces N-formyl amino-salicylamides inhibit oncogenic K-Ras.

Angela A Salim, Kwang-Jin Cho, Lingxiao Tan, Michelle Quezada, Ernest Lacey, John F Hancock, Robert J Capon

Abstract read
In one paragraph

Article in Organic letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Neoantimycin F, aFrontiers in pharmacology · 2019
    Article
  8. Deciphering lipid codes: K-Ras as a paradigm.Traffic (Copenhagen, Denmark) · 2018
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Angela A SalimInstitute for Molecular Bioscience, The University of Queensland , St. Lucia, QLD 4072, Australia.
Kwang-Jin Cho
Lingxiao Tan
Michelle Quezada
Ernest Lacey
John F Hancock
Robert J Capon

Funding

K-Ras plasma membrane interactions: a tractable therapeutic targetR00CA188593 · NCI · WRIGHT STATE UNIVERSITY · PI CHO, KWANGJIN · 2017 to 2019
$747k
K-Ras plasma membrane interactions: a tractable therapeutic targetK99CA188593 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHO, KWANGJIN · 2014 to 2015
$178k
NCI NIH HHS K99 CA188593NCI NIH HHS R00 CA188593
6 · The paper itself

Abstract

During a search for inhibitors of oncogenic K-Ras, we detected two known and two new examples of the rare neoantimycin structure class from a liquid cultivation of Streptomyces orinoci, and reassigned/assigned structures to all based on detailed spectroscopic analysis and microscale C3 Marfey's and C3 Mosher chemical degradation/derivatization/analysis. SAR investigations inclusive of the biosynthetically related antimycins and respirantin, and synthetic benzoxazolone, documented a unique N-formyl amino-salicylamide pharmacophore as a potent inhibitor of oncogenic K-Ras.

Indexed as

ATP Binding Cassette Transporter, Subfamily BDepsipeptidesDoxorubicinGenes, rasMolecular StructureOrganic ChemicalsSalicylamidesStreptomycesStructure-Activity RelationshipATP Binding Cassette Transporter, Subfamily BDepsipeptidesDoxorubicinneoantimycinOrganic ChemicalsrespirantinSalicylamides

Identifiers

PMID25238489
PMCPMC5645021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.